Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 683, Issue 1-3, Pages 238-245Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2012.02.039
Keywords
Carbachol; Detrusor; Glibenclamide; Cyclodextrin; Smooth muscle
Categories
Funding
- Swedish Research Council [K2009-65X-4955-01-3, K2011-67P-20608-02-4]
- ALF
- Crafoord Foundation
- Hillevie Fries Foundation
- Faculty of Medicine at Lund University
Ask authors/readers for more resources
Caveolae are 50-100 nm large membrane invaginations that play a role in cellular signaling. The aim of the present study was to assess whether muscarinic M-3 receptors and the K-ATP channel subunit Kir6.1 are associated with human detrusor caveolae, and to pharmacologically assess the relevance of this organization for contractility. Detrusor strips were dissected and used in ultrastructural, biochemical and mechanical studies. Caveolae were manipulated by cholesterol desorption using m beta cd (methyl-beta-cyclodextrin). M beta cd disrupted caveolae and caused a cholesterol-dependent similar to 3-fold rightward shift of the concentration-response curve for the muscarinic receptor agonist carbachol. The effect of m beta cd was inhibited by the K-ATP blockers glibenclamide, repaglinide and PNU-37883, and it was mimicked by the K-ATP activator levcromakalim. Immunoelectron microscopy showed muscarinic M-3 receptors and Kir6.1 to be enriched in caveolae. In conclusion, pharmacological K-ATP channel inhibition antagonizes the effect of caveolae disruption on muscarinic contractility in the human detrusor, and the K-ATP channel subunit Kir6.1 co-localizes with M3 receptors in caveolae. (C) 2012 Elsevier B. V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available